Anderson Maciel Rocha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anderson Maciel Rocha has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Manuela Berto Pucca
Graduate Program in Bioscience and Biotechnology Applied to Pharmacy, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 19060-900, Brazil
4 shared publications - Eloise T. Monteiro Filardi
Graduate Program in Bioscience and Biotechnology Applied to Pharmacy, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 19060-900, Brazil
2 shared publications - Guilherme Melo-Dos-Santos
Medical School, Universidade Federal de Roraima, Boa Vista 69304-000, Brazil
2 shared publications - Isadora Sousa de Oliveira
Department of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
2 shared publications - Marco Aurélio Sartim
Affiliation Faculdade de Ciências Farmacêuticas, Universidade Federal do Amazonas, Manaus, Brazil
2 shared publications - Wuelton Marcelo Monteiro
Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil
2 shared publications
Latest Publications
- Open Access
Two New Species of Scorpions (Scorpiones: Chactidae) from Northernmost Brazilian Amazon
Amid an ongoing environmental crisis marked by high deforestation rates in the Brazilian Amazon, two new species of chactid scorpions are herein described. Cayooca puchus sp. n. is described from an inselberg in the municipality of Mucajaí, state of Roraima, northern Brazilian Amazon. The new species resembles Cayooca venezuelensis but differs by denser body granulation and strongly costate, scattered granular ventromedian and ventral prosubmedian carinae. Brotheas cernii sp. n., described from the same locality, resembles Brotheas granulatus and B. subgranulatus but differs by smaller body size, granular ventral carinae on metasomal segment I, strongly granular pedipalp chelae, and spinoid granules on ventral metasomal carinae of segments III–V. These findings reinforce the Amazon as a major center of biodiversity and highlight the likelihood that numerous species remain undescribed.
Open AccessTwo New Species of Scorpions (Scorpiones: Chactidae) from Northernmost Brazilian Amazon
Amid an ongoing environmental crisis marked by high deforestation rates in the Brazilian Amazon, two new species of chactid scorpions are herein described. Cayooca puchus sp. n. is described from an inselberg in the municipality of Mucajaí, state of Roraima, northern Brazilian Amazon. The new species resembles Cayooca venezuelensis but differs by denser body granulation and strongly costate, scattered granular ventromedian and ventral prosubmedian carinae. Brotheas cernii sp. n., described from the same locality, resembles Brotheas granulatus and B. subgranulatus but differs by smaller body size, granular ventral carinae on metasomal segment I, strongly granular pedipalp chelae, and spinoid granules on ventral metasomal carinae of segments III–V. These findings reinforce the Amazon as a major center of biodiversity and highlight the likelihood that numerous species remain undescribed.
- Open Access
- 11 November 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (11) , 1583
Phospholipases A2 (PLA2s) and Related Peptides from Bothrops Snake Venoms: History, Structure, Pharmacology, and Inhibitors
Lancehead pitvipers, Bothrops snakes, or, popularly, “jararacas”, are common and broadly distributed in the Americas, especially in Brazil, where they are responsible for causing a high number of snakebite accidents. Their venoms are able to induce local and systemic effects, such as hemorrhaging, acute kidney failure, and shock, that can be fatal. Among the compounds of the venom are phospholipases A2 (PLA2s), which are abundant in some Bothrops species. PLA2s can perform different activities during envenoming, such as neurotoxicity, myotoxicity, and cytotoxicity, among others, through the hydrolysis of the ester bond at the sn-2 position of phospholipids, producing free fatty acids and lysophospholipids. Although different PLA2s can be classified into different PLA2 groups and subgroups, according to structure, function, size, localization and Ca2+ dependence, they converge to be available in biotechnological and therapeutic applications, such as antiviral and antitumor, among others, being relevant molecules to be deeply studied. Here, we provide the state of the art of PLA2s, found in snake venoms, focusing on Bothrops venoms, as well as their potential applications, beyond their inhibitors, that also receive attention due their importance in PLA2 studies and diverse applications.
- 11 November 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (11) , 1583
Open AccessPhospholipases A2 (PLA2s) and Related Peptides from Bothrops Snake Venoms: History, Structure, Pharmacology, and Inhibitors
Lancehead pitvipers, Bothrops snakes, or, popularly, “jararacas”, are common and broadly distributed in the Americas, especially in Brazil, where they are responsible for causing a high number of snakebite accidents. Their venoms are able to induce local and systemic effects, such as hemorrhaging, acute kidney failure, and shock, that can be fatal. Among the compounds of the venom are phospholipases A2 (PLA2s), which are abundant in some Bothrops species. PLA2s can perform different activities during envenoming, such as neurotoxicity, myotoxicity, and cytotoxicity, among others, through the hydrolysis of the ester bond at the sn-2 position of phospholipids, producing free fatty acids and lysophospholipids. Although different PLA2s can be classified into different PLA2 groups and subgroups, according to structure, function, size, localization and Ca2+ dependence, they converge to be available in biotechnological and therapeutic applications, such as antiviral and antitumor, among others, being relevant molecules to be deeply studied. Here, we provide the state of the art of PLA2s, found in snake venoms, focusing on Bothrops venoms, as well as their potential applications, beyond their inhibitors, that also receive attention due their importance in PLA2 studies and diverse applications.
- Open Access
- 6 January 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (1) , 54
Comparative Analysis of the Enzymatic, Coagulant, and Neuromuscular Activities of Two Variants of Crotalus durissus ruruima Venom and Antivenom Efficacy
Background: We compared the enzymatic, coagulant, and neuromuscular activities of two variants (yellow—CDRy and white—CDRw) of Crotalus durissus ruruima venom with a sample of C. d. terrificus (CDT) venom and examined their neutralization by antivenom against CDT venom. Methods: The venoms were screened for enzymatic and coagulant activities using standard assays, and electrophoretic profiles were compared by SDS-PAGE. Neutralization was assessed by preincubating venoms with crotalic antivenom and assaying the residual activity. Results: SDS-PAGE showed that the venoms had similar electrophoretic profiles, with the main bands being phospholipase A2 (PLA2), serine proteinases, L-amino acid oxidase (LAAO), and phosphodiesterase. CDRy venom had the highest proteolytic and LAAO activities, CDRw venom had greater PLA2 and esterolytic activities at the highest quantity tested, and CDT had greater PLA2 activity than CDRy. CDRw and CDT venoms had similar proteolytic and LAAO activities, and CDRy and CDT venoms had comparable esterolytic activity. None of the venoms altered the prothrombin time (PT), but all of them decreased the activated partial thromboplastin time (aPPT); this activity was neutralized by antivenom. The minimum coagulant dose potency was CDRw >> CDRy > CDT. All venoms had thrombin-like activity that was attenuated by antivenom. CDRy and CDRw venoms showed α-fibrinogenolytic activity. All venoms partially cleaved the β-chain. CDRy and CDT venoms caused neuromuscular facilitation (enhanced muscle contractions) followed by complete blockade, whereas CDRw venom caused only blockade. Antivenom neutralized the neuromuscular activity to varying degrees. Conclusions: These findings indicate that while CDR and CDT venoms share similarities, they also differ in some enzymatic and biological activities and in neutralization by antivenom. Some of these differences could influence the clinical manifestations of envenomation by C. d. ruruima and their neutralization by the currently used therapeutic antivenom.
- 6 January 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (1) , 54
Open AccessComparative Analysis of the Enzymatic, Coagulant, and Neuromuscular Activities of Two Variants of Crotalus durissus ruruima Venom and Antivenom Efficacy
Background: We compared the enzymatic, coagulant, and neuromuscular activities of two variants (yellow—CDRy and white—CDRw) of Crotalus durissus ruruima venom with a sample of C. d. terrificus (CDT) venom and examined their neutralization by antivenom against CDT venom. Methods: The venoms were screened for enzymatic and coagulant activities using standard assays, and electrophoretic profiles were compared by SDS-PAGE. Neutralization was assessed by preincubating venoms with crotalic antivenom and assaying the residual activity. Results: SDS-PAGE showed that the venoms had similar electrophoretic profiles, with the main bands being phospholipase A2 (PLA2), serine proteinases, L-amino acid oxidase (LAAO), and phosphodiesterase. CDRy venom had the highest proteolytic and LAAO activities, CDRw venom had greater PLA2 and esterolytic activities at the highest quantity tested, and CDT had greater PLA2 activity than CDRy. CDRw and CDT venoms had similar proteolytic and LAAO activities, and CDRy and CDT venoms had comparable esterolytic activity. None of the venoms altered the prothrombin time (PT), but all of them decreased the activated partial thromboplastin time (aPPT); this activity was neutralized by antivenom. The minimum coagulant dose potency was CDRw >> CDRy > CDT. All venoms had thrombin-like activity that was attenuated by antivenom. CDRy and CDRw venoms showed α-fibrinogenolytic activity. All venoms partially cleaved the β-chain. CDRy and CDT venoms caused neuromuscular facilitation (enhanced muscle contractions) followed by complete blockade, whereas CDRw venom caused only blockade. Antivenom neutralized the neuromuscular activity to varying degrees. Conclusions: These findings indicate that while CDR and CDT venoms share similarities, they also differ in some enzymatic and biological activities and in neutralization by antivenom. Some of these differences could influence the clinical manifestations of envenomation by C. d. ruruima and their neutralization by the currently used therapeutic antivenom.
- Open Access
The State-of-the-Art of the Humoral Memory Response to Snakebites: Insights from the Yanomami Population
Snakebite envenomation (SBE)-induced immunity refers to individuals who have been previously bitten by a snake and developed a protective immune response against subsequent envenomations. The notion stems from observations of individuals, including in the indigenous population, who present only mild signs and symptoms after surviving multiple SBEs. Indeed, these observations have engendered scientific interest and prompted inquiries into the potential development of a protective immunity from exposure to snake toxins. This review explores the evidence of a protective immune response developing following SBE. Studies suggest that natural exposure to snake toxins can trigger protection from the severity of SBEs, mediated by specific antibodies. However, the evaluation of the immune memory response in SBE patients remains challenging. Further research is needed to elucidate the immune response dynamics and identify potential targets for therapeutic interventions. Furthermore, the estimation of the effect of previous exposures on SBE epidemiology in hyperendemic areas, such as in the indigenous villages of the Amazon region (e.g., the Yanomami population) is a matter of debate.
Open AccessThe State-of-the-Art of the Humoral Memory Response to Snakebites: Insights from the Yanomami Population
Snakebite envenomation (SBE)-induced immunity refers to individuals who have been previously bitten by a snake and developed a protective immune response against subsequent envenomations. The notion stems from observations of individuals, including in the indigenous population, who present only mild signs and symptoms after surviving multiple SBEs. Indeed, these observations have engendered scientific interest and prompted inquiries into the potential development of a protective immunity from exposure to snake toxins. This review explores the evidence of a protective immune response developing following SBE. Studies suggest that natural exposure to snake toxins can trigger protection from the severity of SBEs, mediated by specific antibodies. However, the evaluation of the immune memory response in SBE patients remains challenging. Further research is needed to elucidate the immune response dynamics and identify potential targets for therapeutic interventions. Furthermore, the estimation of the effect of previous exposures on SBE epidemiology in hyperendemic areas, such as in the indigenous villages of the Amazon region (e.g., the Yanomami population) is a matter of debate.